#StopRxGreed

istockphoto.com/Sezeryadigar
AARP Deeply Concerned by Cuts to Medicaid-Funded Long-Term Care; Urges Revisiting in Near Future
Rx L I Day of Action 2.jpg
Urge Rx Price Control Board, ‘EPIC’ Expansion in New State Budget Due April 1
Rx NYS survey rollout press conference 1-28-20.jpg
AARP Urges NYS Lawmakers to Support Proposals to Increase Accessibility of Affordable Drugs, Crack Down on Price Gouging, Expose Costly Deals
NYS Capitol steps with volunteers.jpg
AARP Supports Rx, Robocall, Banking, Debt Collection, Healthcare Transparency Measures; Also Calls for Cost-Effective Tax Credit for Unpaid Family Caregivers
Stop-rx-greed-red.web.jpg
Three-Part Package Increases Accessibility of Affordable Drugs, Aims to Stop Price Gouging
Rx drug price hikes $110 B.gif
It’s well known that prescription drug prices are skyrocketing in America. Price increases for brand name drugs have far exceeded the rate of inflation since at least 2006, according to AARP’s Rx Price Watch report. And, the average annual cost for just one brand name drug taken on a chronic basis was about $6,800 in 2017, almost $1,000 more than in 2015. However, it’s not just patients paying for greedy Big Pharma practices that help keep drug prices high— it’s also taxpayers.
Prescription medicine and money
Proposed bills would protect consumers
Search AARP New York